Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Application based on results from the TROPION-Lung01 Phase III trial If approved, AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan may be the first TROP2-directed... Read more.
TAGRISSO® (osimertinib) demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial
First EGFR inhibitor and targeted treatment to demonstrate progression-free survival benefit in Stage III setting WILMINGTON, Del.–(BUSINESS WIRE)–Positive... Read more.
Pulsate Raises $7.75M in Series A Funding Backed By TruStage Ventures and Curql
DUBLIN–(BUSINESS WIRE)–In response to continued demand for better consumer engagement tools for the digital channel, Pulsate, provider of mobile-first... Read more.
Pulsate Raises $7.75M in Series A Funding Backed By TruStage Ventures and Curql
DUBLIN–(BUSINESS WIRE)–In response to continued demand for better consumer engagement tools for the digital channel, Pulsate, provider of mobile-first... Read more.
Fluor to Participate in Upcoming Investor Conferences
IRVING, Texas–(BUSINESS WIRE)–Fluor Corporation (NYSE: FLR) today announced that Jason Landkamer, Executive Director- Investor Relations will be hosting... Read more.
NEC and D-Wave Introduce New Quantum Offerings to Australian Market
SYDNEY & PALO ALTO, Calif. & BURNABY, British Columbia–(BUSINESS WIRE)–NEC Australia and leading international quantum computing company, D-Wave... Read more.
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable... Read more.
Fiserv Appoints Lance Fritz to Board of Directors
BROOKFIELD, Wis.–(BUSINESS WIRE)–Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, today announced the... Read more.
Antimicrobial Resistance Diagnostic Markets Transforming Global Healthcare with Innovative Technologies and Trends 2023-2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides... Read more.
Fungies.io Unveils a Web Store Platform & Anticipates $60 Billion Surge in Direct-to-Consumer Revenue across the 1.5 Billion Global Gamers Market.
PALO ALTO, Calif.–(BUSINESS WIRE)–#gamecommerce–Fungies.io launches a Web Store platform, to allow mobile game publishers and developers to reach... Read more.